Around 60% of children with high-risk neuroblastoma could be treated with dinutuximab beta
Hundreds of patients a year set to benefit from roll out of dye to all of England’s neurosurgical units
A quick look at the guidance and advice that has generated the most interest during the first half of the year.
Latest NICE guidance aims to help improve and standardise the diagnosis, treatment and monitoring of myeloma.
NICE prioritises four areas of head and neck cancer care for improvement.
Decisions around whether to offer a person surgical treatment should not be based on age and fitness, according to a new report.
Men undergoing active surveillance for prostate cancer, which can avoid or delay unnecessary treatment, should have their prostate specific antigen (PSA) levels measured every 3-4 months initially, according to updated guidelines from NICE.
NICE has recommended the Intrabeam Radiotherapy System for people with early breast cancer in limited circumstances with additional data collection.
Two new quality standards on colorectal cancer and stable angina have been launched this month, as NICE expands its library of standards.